Skip to content

Travere Therapeutics, Inc. TVTX Other Non-Current Assets

Other Non-Current Assets at other companies

LQD
Liquidia CorporationLQDA
$16.9M+8.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$18.62M+12.1%
Arrowhead Research logo
Arrowhead ResearchARWR
$4.89M+272%
Scholar Rock logo
Scholar RockSRRK
$4.59M+60.6%
United Therapeutics logo
United TherapeuticsUTHR
$233.2M+4.9%
Incyte logo
IncyteINCY
$24.49M-18.8%

Other financials

Income statement

See full
Revenue$127.2M+55.6%
Gross profit$125.2M+62.5%
Operating income-$36.9M+13.5%
Net income-$37.1M+10.0%
EPS (diluted)-$0.40+14.9%

Balance sheet

See full
Cash & equivalents$78.4M+26.6%
Total debt$15.6M-82.6%
Total equity$98.7M+201%
Total assets$555.2M+1.2%

Cash flow

See full
Operating cash flow-$40.4M+4.3%
CapEx$140.0K
Free cash flow-$42.5M+28.1%

Valuation

See full
Market cap$5.13B+72.3%
Enterprise value$5.07B+65.5%
P/S9.6×-1.3×

Profitability

See full
Gross margin98.6%+2.6pp
Operating margin-10.6%-5.0pp
Net margin-20.3%-9.5pp
FCF margin-133.9%-34.4pp

Returns & leverage

See full
Return on equity-706%-1,302pp
Debt / equity0.2×-2.6×
Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s other non-current assets?
Travere Therapeutics, Inc. (TVTX) reported other non-current assets of $8.48M in Q1 2026.
How has Travere Therapeutics, Inc.'s other non-current assets changed year-over-year?
Travere Therapeutics, Inc.'s other non-current assets decreased by 54.6% year-over-year, from $18.69M to $8.48M.
What is the long-term trend for Travere Therapeutics, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s other non-current assets has grown at a 2.6% compound annual growth rate (CAGR), from $7.81M to $8.88M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.